K Karunakaran1
,
G Navaneethan1,
K P Elango2
1Department of Chemistry, Sona College of Technology, Anna University, Salem 636 005;
2Department of Chemistry, Gandhigram Rural Institute, Deemed University, Gandhigram 624302, India.
For correspondence:- K Karunakaran
Email: drkk@sonatech.ac.in Tel:+914274099998
Received: 1 March 2011
Accepted: 20 August 2011
Published: 23 October 2011
Citation:
Karunakaran K, Navaneethan G, Elango KP.
Development of a New RP-UPLC Method for the Determination of Rabeprazole Sodium in Pharmaceutical Formulation and Application in Dissolution Studies. Trop J Pharm Res 2011; 10(5):655-661
doi:
10.4314/tjpr.v10i5.15
© 2011 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To develop a reverse phase ultra-performance liquid chromatographic (RP-UPLC) method for the estimation of rabeprazole sodium in tablet formulations.
Methods: Chromatographic separation was achieved on a Waters Acquity BEH C18 (50 x 2.1 mm, particle size 1.7 µm) column using an isocratic method with mobile phase composed of acetonitrile and phosphate buffer (pH 7.4) in the ratio of 35:65 (v/v). The flow rate was 0.4 ml/min, temperature of the column was maintained at ambient, injection volume was 5 µL and detection was made at 280 nm. The run time was as short as 2 min. Comparison of system performance with conventional HPLC was made with respect to analysis time, efficiency and sensitivity.
Results: The developed method was linear for rabeprazole sodium from 0.03 - 30 µg/ml and the linear regression obtained was > 0.999. Precision, evaluated by intra- and inter-day assay,s had relative standard deviation (R.S.D) values within 1.5 %. Recovery data were in the range 98.0 - 101.5 % with R.S.D. values < 1.5 %.
Conclusion: The method is precise, accurate, linear, robust and fast. The short retention time of 1.49 min allows the analysis of a large number of samples in a short period of time and, therefore, should be cost-effective for routine analysis in the pharmaceutical industry.
Keywords: Ultra performance liquid chromatography, Assay, Rabeprazole sodium, Validation